Oslo, Norway, 7 January, 2019 – Photocure ASA (OSE: PHO) management is this week conducting investor meetings in San Francisco (US) in connection with the J.P. Morgan healthcare conference.
Please find the presentation attached: JP Morgan Jan 2019 (https://mb.cision.com/Public/17498/2712264/a1e17da1e1e8beff.pdf)
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
About Photocure ASA
Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com.
Se fullständiga pressmeddelande och andra nyheter från detta bolag hos Cision News